With HVAD Out, Innovation Key to Mechanical Circulatory Support A debate on where LVAD innovation stands Sep 14, 2021
Transplant Docs Are Sticking With Invasive Biopsies After Heart Transplants Agreement that non-invasive alternatives to EMB are not ready for routine rejection surveillance Sep 13, 2021
SGLT2 Inhibitor Eases Symptoms for HFpEF Patients Trial suggests hard outcomes not the only ones helped by this class of medication Sep 13, 2021
Second-Gen Drug for HCM Emerges, Nipping at Mavacamten's Heels Novel cardiac myosin inhibitor is headed for a phase III trial Sep 12, 2021
Heart Failure's 'Golden Moment' Not Translating into Better Health Problems of implementation and health equity persist Sep 12, 2021
Feared ARNI Effect on Cognition Hasn't Come to Fruition Neurocognitive protection by sacubitril/valsartan suggested instead by observational study Sep 12, 2021
Good Results When Giving Flu Shots to MI Survivors Still in the Hospital Vaccination prior to discharge linked to heart benefit Aug 30, 2021
Polypills Ready for Prime Time in Large Swaths of People, Researchers Say Question now is how to implement fixed-dose combo therapy in clinical practice Aug 29, 2021
His Bundle Pacing Stars in European Guidelines Revised edition could signal coming U.S. recommendations too Aug 29, 2021
Ablation, CRT Boost Survival in Permanent Afib With Narrow QRS APAF-CRT trial reinforces the case for expanded CRT indication Aug 28, 2021
Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
A Familiar Drug Can Keep Early-Stage HCM at Bay Treatment with valsartan most beneficial when started early? Aug 27, 2021
Empagliflozin Improves Outcomes in HFpEF Patients "A major win" for heart failure with preserved ejection fraction, says editorialist Aug 27, 2021
New Heart Failure Guidelines Released, but Are They Already Out of Date? Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
Milder Heart Failure Might Benefit From Implantable Monitors Randomized trial signals benefit, albeit hampered by the pandemic Aug 27, 2021
Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozin DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021
Heart Failure Again Takes Center Stage at ESC EMPEROR-Preserved, new guidelines, and more to come Aug 26, 2021
Inotrope Showdown Leaves No Winner in Cardiogenic Shock Long-awaited head-to-head comparison of milrinone and dobutamine Aug 04, 2021
TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
Start Rhythm Control Early for Afib With Heart Failure EAST-AFNET 4 trial finds similar benefits across ejection fraction ranges Jul 31, 2021
SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure DAPA-HF group makes projections as long-term data are lacking Jul 28, 2021
Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits More insight into mechanisms behind empagliflozin's cardioprotection Jul 26, 2021
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
Does COAPT Change the Need to Try Foundational HF Drugs in Functional MR? Current GDMT titration approach under fire during TVT debate Jul 21, 2021
After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be Unlikely Are observational data on highly selected patients good enough? Jul 21, 2021
Scarring on an Otherwise Normal Heart: Reassuring Data Emerge Phenomenon tied to very low burden of major arrhythmic events Jul 14, 2021
Academic Cardiologists Singled Out for Gender Equality Problem Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
Regenerative Therapy Makes Headway in HF ... in the Right Patients Study of autologous skeletal cell-patch implantation in Japan Jul 02, 2021
First TTS Case After mRNA Shot; Fake Fellow Strikes Out; Disappearing Pacemaker Recent developments of interest in cardiovascular medicine Jun 29, 2021
First Close Look at Presumed Myocarditis Cases After COVID Vaccination Case reports suggest a favorable clinical course after hospitalization Jun 17, 2021
Best MIS-C Treatment? Murky Picture Emerges Large U.S. and international surveillance data series come to conflicting conclusions Jun 16, 2021
Early Vax Myocarditis Data; Novel RAAS Inhibitor; Star Athletes Collapse Mid-Game Recent developments of interest in cardiovascular medicine Jun 14, 2021
Op-Ed: Does Your Patient Really Have Diastolic Dysfunction? The Skeptical Cardiologist highlights the confusion in "diastology" Jun 05, 2021
Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions A glance at devices coming down the structural heart pipeline in the coming years May 24, 2021
Navitor Shuts Out Leaky TAVR, but Pacemaker Rates a Concern? 30-day data for a new version of the Portico valve May 20, 2021
Adverse Events Drop With Fuller Accounting of Evolut Low Risk Trial Yet worrying signals with TAVR remain May 19, 2021
Entresto Risky for Advanced Heart Failure? LIFE trial "not only disappointed but surprised" with its findings May 17, 2021
Pacemaker Interference Warning; Religious Fasting and CVD; Toothpick in the Heart Recent developments of interest in cardiovascular medicine May 17, 2021
